List view / Grid view

Nathalie Moll

 

news

European PFAS restriction could jeopardise pharmaceutical manufacturing

Pharmaceutical manufacturing in Europe is at risk of critical medicine…

28 September 2023 | By

Pharmaceutical manufacturing in Europe is at risk of critical medicine shortages, states the European Federation of Pharmaceutical Industries and Associations (EFPIA), if the widest chemical substance restriction, concerning Per- and Polyfluoroalkyl Substances (PFAS), is put in place.